Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A pan-cancer analysis of the microbiome in metastatic cancer.
Cell. 2024 Apr 25;187(9):2324-2335.e19. doi: 10.1016/j.cell.2024.03.021. Epub 2024 Apr 9.
Cell. 2024.
PMID: 38599211
Free article.
γδ T cells are effectors of immunotherapy in cancers with HLA class I defects.
de Vries NL, van de Haar J, Veninga V, Chalabi M, Ijsselsteijn ME, van der Ploeg M, van den Bulk J, Ruano D, van den Berg JG, Haanen JB, Zeverijn LJ, Geurts BS, de Wit GF, Battaglia TW, Gelderblom H, Verheul HMW, Schumacher TN, Wessels LFA, Koning F, de Miranda NFCC, Voest EE.
de Vries NL, et al. Among authors: de wit gf.
Nature. 2023 Jan;613(7945):743-750. doi: 10.1038/s41586-022-05593-1. Epub 2023 Jan 11.
Nature. 2023.
PMID: 36631610
Free PMC article.
Item in Clipboard
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours.
Geurts BS, Battaglia TW, van Berge Henegouwen JM, Zeverijn LJ, de Wit GF, Hoes LR, van der Wijngaart H, van der Noort V, Roepman P, de Leng WWJ, Jansen AML, Opdam FL, de Jonge MJA, Cirkel GA, Labots M, Hoeben A, Kerver ED, Bins AD, Erdkamp FGL, van Rooijen JM, Houtsma D, Hendriks MP, de Groot JB, Verheul HMW, Gelderblom H, Voest EE.
Geurts BS, et al. Among authors: de wit gf.
BMC Cancer. 2023 Mar 4;23(1):205. doi: 10.1186/s12885-023-10663-2.
BMC Cancer. 2023.
PMID: 36870947
Free PMC article.
Item in Clipboard
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.
Spiekman IAC, Geurts BS, Zeverijn LJ, de Wit GF, van der Noort V, Roepman P, de Leng WWJ, Jansen AML, Kusters B, Beerepoot LV, de Vos FYFL, de Groot DA, de Groot JWB, Hoeben A, Buter J, Gelderblom HAJ, Voest EE, Verheul HMW.
Spiekman IAC, et al. Among authors: de wit gf.
Oncologist. 2024 May 3;29(5):431-440. doi: 10.1093/oncolo/oyad320.
Oncologist. 2024.
PMID: 38109296
Free PMC article.
Item in Clipboard
Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy.
Geurts BS, Zeverijn LJ, van Berge Henegouwen JM, van der Wijngaart H, Hoes LR, de Wit GF, Spiekman IA, Battaglia TW, van Beek DM, Roepman P, Jansen AM, de Leng WW, Broeks A, Labots M, van Herpen CM, Gelderblom H, Verheul HM, Snaebjornsson P, Voest EE.
Geurts BS, et al. Among authors: de wit gf.
J Pathol. 2024 May 15. doi: 10.1002/path.6279. Online ahead of print.
J Pathol. 2024.
PMID: 38747304
Item in Clipboard
Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials.
Zeverijn LJ, Looze EJ, Thavaneswaran S, van Berge Henegouwen JM, Simes RJ, Hoes LR, Sjoquist KM, van der Wijngaart H, Sebastian L, Geurts BS, Lee CK, de Wit GF, Espinoza D, Roepman P, Lin FP, Jansen AML, de Leng WWJ, van der Noort V, Leek LVM, de Vos FYFL, van Herpen CML, Gelderblom H, Verheul HMW, Thomas DM, Voest EE.
Zeverijn LJ, et al. Among authors: de wit gf.
Int J Cancer. 2023 Oct 1;153(7):1413-1422. doi: 10.1002/ijc.34649. Epub 2023 Jul 10.
Int J Cancer. 2023.
PMID: 37424386
Clinical Trial.
Item in Clipboard
Beyond Skin Rash: Alpelisib-Induced Anaphylactic Reactions.
Schutte T, Zeverijn LJ, Geurts BS, de Wit GF, Kok M, Opdam FL.
Schutte T, et al. Among authors: de wit gf.
Oncologist. 2023 Jul 5;28(7):e493-e497. doi: 10.1093/oncolo/oyad092.
Oncologist. 2023.
PMID: 37086483
Free PMC article.
Item in Clipboard
Harmonising patient-access programmes: the Dutch DRUG Access Protocol platform.
Zeverijn LJ, van Waalwijk van Doorn-Khosrovani SB, van Roy AAMGP, Timmers L, Ly Tran TH, de Boer JE, de Wit GF, Geurts BS, Gelderblom H, Verheul HMW, Blijlevens N, Wymenga ANM, Eskens FALM, Smit EF, Bloemendal HJ, Voest EE.
Zeverijn LJ, et al. Among authors: de wit gf.
Lancet Oncol. 2022 Feb;23(2):198-201. doi: 10.1016/S1470-2045(21)00707-5.
Lancet Oncol. 2022.
PMID: 35114116
No abstract available.
Item in Clipboard
Cite
Cite